We aim to ensure relevant, accurate and timely information is available to our investors and the rest of the financial community. Genmab's ordinary shares are listed on the Nasdaq Copenhagen and American Depository Shares issued under its ADR Program are listed on the Nasdaq Global Select Market in the United States under the ticker symbol GMAB.
As part of our Investor Relations activities we:
- Observe quiet periods two weeks before issuing financial reports with no broad discussions with investors and financial analysts
- Issue announcements about relevant news and developments regarding our company, products, technologies and partnerships
- Hold regular analyst and investor meetings to discuss our financial reports or other important news events
- Provide financial guidance for the year
- Maintain an updated website that includes corporate documents, financial reports, stock information and other information on the company, including our leadership, products and technology
- Have a dedicated IR contact person.